摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

4-hydroxycyclohexylacetaldehyde | 1357255-94-7

中文名称
——
中文别名
——
英文名称
4-hydroxycyclohexylacetaldehyde
英文别名
2-(4-hydroxycyclohexyl)acetaldehyde
4-hydroxycyclohexylacetaldehyde化学式
CAS
1357255-94-7
化学式
C8H14O2
mdl
——
分子量
142.198
InChiKey
FWXAHLLBJDQYEF-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    0.5
  • 重原子数:
    10
  • 可旋转键数:
    2
  • 环数:
    1.0
  • sp3杂化的碳原子比例:
    0.88
  • 拓扑面积:
    37.3
  • 氢给体数:
    1
  • 氢受体数:
    2

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为产物:
    描述:
    (4-oxocyclohexyl)acetaldehyde 在 RunanoHAP 、 1,3-丙二醇氢气 作用下, 以 1,4-二氧六环 为溶剂, 30.0~80.0 ℃ 、101.33 kPa 条件下, 反应 1.5h, 以93%的产率得到4-hydroxycyclohexylacetaldehyde
    参考文献:
    名称:
    在以下条件下,酮的原子效率高且化学选择性还原 醛类 使用非均相催化剂
    摘要:
    100%原子效率选择性的首次演示 减少 反应性较低 酮类 超过 醛类 使用异构 催化剂被报道。分子内和分子间还原异戊二烯的选择性极高酮类 超过 醛类实现了。该系统还适用于柱反应器,导致克级合成。
    DOI:
    10.1039/c3gc41322e
点击查看最新优质反应信息

文献信息

  • Reversing the Reactivity of Carbonyl Functions with Phosphonium Salts: Enantioselective Total Synthesis of (+)-Centrolobine
    作者:Hiromichi Fujioka、Kenzo Yahata、Ozora Kubo、Yoshinari Sawama、Tomohito Hamada、Tomohiro Maegawa
    DOI:10.1002/anie.201106046
    日期:2011.12.16
    Step saver: Carbonyl groups with lower reactivities can be transformed in the presence of more reactive ones by treatment with PPh3 (or PEt3) and TMSOTf prior to the reaction (see scheme; TMS=trimethylsilyl, Tf=trifluoromethanesulfonyl). This methodology can be applied to reduction and alkylation reactions, and enabled the short asymmetric total synthesis of (+)‐centrolobine with the highest overall
    节省步骤的方法:在反应之前,可以通过用PPh 3(或PEt 3)和TMSOTf处理,在反应性更高的羰基存在下转化(参见方案; TMS =三甲基甲硅烷基,Tf =三氟甲磺酰基)。该方法学可用于还原和烷基化反应,并实现了迄今为止报道的最高总收率的(+)-中心ro素的短时不对称全合成。
  • Highly atom-efficient and chemoselective reduction of ketones in the presence of aldehydes using heterogeneous catalysts
    作者:Yusuke Takahashi、Takato Mitsudome、Tomoo Mizugaki、Koichiro Jitsukawa、Kiyotomi Kaneda
    DOI:10.1039/c3gc41322e
    日期:——
    The first demonstration of a 100% atom-efficient selective reduction of less reactive ketones over aldehydes using heterogeneous catalysts is reported. Extremely high selectivities for intra- and intermolecular reductions of ketones over aldehydes were achieved. This system was also applicable to a column reactor, leading to a gram-scale synthesis.
    100%原子效率选择性的首次演示 减少 反应性较低 酮类 超过 醛类 使用异构 催化剂被报道。分子内和分子间还原异戊二烯的选择性极高酮类 超过 醛类实现了。该系统还适用于柱反应器,导致克级合成。
  • DEAZAPURINES AND USES THEREOF
    申请人:Eisai Co. Ltd.
    公开号:EP1474425A1
    公开(公告)日:2004-11-10
  • DALBAVANCIN COMPOSITIONS FOR TREATMENT OF BACTERIAL INFECTIONS
    申请人:Stogniew Martin
    公开号:US20090298749A1
    公开(公告)日:2009-12-03
    The invention provides methods and compositions for treatment of bacterial infections. The composition may be a combination of factors, which include A 0 , A 1 , B 1 , B 2 , C 0 , C 1 , isoB 0 , and MAG, in the presence of low level solvent. Methods of the invention include administration of dalbavancin formulations for treatment of a bacterial infection, in particular a Gram-positive bacterial infection of skin and soft tissue. Dosing regimens include multiple dose administration of dalbavancin, which often remains at therapeutic levels in the bloodstream for at least one week, providing prolonged therapeutic action against a bacterial infection. Dosing regimens for renal patients are also included.
  • [EN] DEAZAPURINES AND USES THEREOF<br/>[FR] DEAZAPURINES ET LEURS UTILISATIONS
    申请人:EISAI CO LTD
    公开号:WO2003057696A1
    公开(公告)日:2003-07-17
    The present invention provides compounds having formula (I), wherein R1, R2, R3 and n are as described generally and in classes and subclasses herein, and additionally provides pharmaceutical compositions thereof, and methods for the use thereof in the treatment of inflammatory or autoimmune and proliferative disorders and as inhibitors of cell adhesion molecule expression and inflammatory cytokine signal transduction generally.
查看更多